Jefferies Group LLC Cara Therapeutics, Inc. Put Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$18.28 - $26.91 $274,200 - $403,650
-15,000 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$17.68 - $21.57 $265,200 - $323,550
15,000 New
15,000 $323,000
Q1 2018

May 15, 2018
SELL
$11.77 - $16.08 $218,922 - $299,087
-18,600 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$11.86 - $14.08 $521,840 - $619,520
-44,000 Reduced 70.29%
18,600 $228,000
Q3 2017

Nov 14, 2017
BUY
$12.6 - $16.34 $788,760 - $1.02 Million
62,600
62,600 $857,000

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $15M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email